» Articles » PMID: 18320564

RNA Interference: an Emerging Generation of Biologicals

Overview
Journal Biotechnol J
Specialty Biotechnology
Date 2008 Mar 6
PMID 18320564
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

RNA interference (RNAi) is a mechanism displayed by most eukaryotic cells to rid themselves of foreign double-stranded RNA molecules. RNAi has now been demonstrated to function in mammalian cells to alter gene expression, and has been used as a means for genetic discovery as well as a possible strategy for genetic correction. RNAi was first described in animal cells by Fire and colleagues in the nematode, Caenorhabditis elegans. Knowledge of RNAi mechanism in mammalian cell in 2001 brought a storm in the field of drug discovery. During the past few years scientists all over the world are focusing on exploiting the therapeutic potential of RNAi for identifying a new class of therapeutics. The applications of RNAi in medicine are unlimited because all cells possess RNAi machinery and hence all genes can be potential targets for therapy. RNAi can be developed as an endogenous host defense mechanism against many infections and diseases. Several studies have demonstrated therapeutic benefits of small interfering RNAs and micro RNAs in animal models. This has led to the rapid advancement of the technique from research discovery to clinical trials.

Citing Articles

Cancer therapeutic targeting using mutant-p53-specific siRNAs.

Ubby I, Krueger C, Rosato R, Qian W, Chang J, Sabapathy K Oncogene. 2019; 38(18):3415-3427.

PMID: 30643191 PMC: 6756012. DOI: 10.1038/s41388-018-0652-y.


CRISPR Gene Editing in Yeast: An Experimental Protocol for an Upper-Division Undergraduate Laboratory Course.

Sehgal N, Sylves M, Sahoo A, Chow J, Walker S, Cullen P Biochem Mol Biol Educ. 2018; 46(6):592-601.

PMID: 30311729 PMC: 6615721. DOI: 10.1002/bmb.21175.


MicroRNA in Glioblastoma: An Overview.

Banelli B, Forlani A, Allemanni G, Morabito A, Pistillo M, Romani M Int J Genomics. 2017; 2017:7639084.

PMID: 29234674 PMC: 5695025. DOI: 10.1155/2017/7639084.


Targeting MACC1 by RNA interference inhibits proliferation and invasion of bladder urothelial carcinoma in T24 cells.

Xu S, Ding X, Ni Q, Jin S Int J Clin Exp Pathol. 2015; 8(7):7937-44.

PMID: 26339359 PMC: 4555687.


The effects of p38 gene silencing on breast cancer cells.

Doganer F, Cosan D, Gunes H, Degirmenci I, Bal C Mol Biol Rep. 2014; 41(5):2923-7.

PMID: 24464183 DOI: 10.1007/s11033-014-3148-z.


References
1.
Layzer J, McCaffrey A, Tanner A, Huang Z, Kay M, Sullenger B . In vivo activity of nuclease-resistant siRNAs. RNA. 2004; 10(5):766-71. PMC: 1370566. DOI: 10.1261/rna.5239604. View

2.
Brennecke J, Hipfner D, Stark A, Russell R, Cohen S . bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell. 2003; 113(1):25-36. DOI: 10.1016/s0092-8674(03)00231-9. View

3.
Tsunoda S, Mazda O, Oda Y, Iida Y, Akabame S, Kishida T . Sonoporation using microbubble BR14 promotes pDNA/siRNA transduction to murine heart. Biochem Biophys Res Commun. 2005; 336(1):118-27. DOI: 10.1016/j.bbrc.2005.08.052. View

4.
Li M, Li H, Rossi J . RNAi in combination with a ribozyme and TAR decoy for treatment of HIV infection in hematopoietic cell gene therapy. Ann N Y Acad Sci. 2006; 1082:172-9. DOI: 10.1196/annals.1348.006. View

5.
Akaneya Y, Jiang B, Tsumoto T . RNAi-induced gene silencing by local electroporation in targeting brain region. J Neurophysiol. 2004; 93(1):594-602. DOI: 10.1152/jn.00161.2004. View